Glenmede Trust’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-440
| Closed | -$20K | – | 1522 |
|
|
2020
Q3 | $20K | Buy |
440
+20
| +5% | +$909 | ﹤0.01% | 1620 |
|
|
2020
Q2 | $21K | Buy |
420
+306
| +268% | +$15.3K | ﹤0.01% | 1569 |
|
|
2020
Q1 | $7K | Hold |
114
| – | – | ﹤0.01% | 2559 |
|
|
2019
Q4 | $7K | Sell |
114
-66
| -37% | -$4.05K | ﹤0.01% | 2559 |
|
|
2019
Q3 | $9 | Buy |
180
+7
| +4% | – | ﹤0.01% | 2393 |
|
|
2019
Q2 | $13 | Buy |
173
+116
| +204% | +$9 | ﹤0.01% | 2260 |
|
|
2019
Q1 | $5 | Hold |
57
| – | – | ﹤0.01% | 2603 |
|
|
2018
Q4 | $4 | Buy |
+57
| New | +$4 | ﹤0.01% | 2596 |
|
|
2016
Q3 | – | Sell |
-1,000
| Closed | -$22K | – | 2604 |
|
|
2016
Q2 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 1866 |
|
|
2016
Q1 | $29K | Hold |
1,000
| – | – | ﹤0.01% | 1691 |
|
|
2015
Q4 | $33K | Sell |
1,000
-19,200
| -95% | -$634K | ﹤0.01% | 1706 |
|
|
2015
Q3 | $729K | Buy |
20,200
+19,200
| +1,920% | +$693K | 0.01% | 798 |
|
|
2015
Q2 | $44K | Hold |
1,000
| – | – | ﹤0.01% | 1674 |
|
|
2015
Q1 | $30K | Sell |
1,000
-407,476
| -100% | -$12.2M | ﹤0.01% | 1830 |
|
|
2014
Q4 | $20.8M | Buy |
408,476
+80,821
| +25% | +$4.11M | 0.16% | 199 |
|
|
2014
Q3 | $13M | Buy |
327,655
+102,486
| +46% | +$4.05M | 0.11% | 267 |
|
|
2014
Q2 | $9.7M | Buy |
225,169
+224,169
| +22,417% | +$9.65M | 0.09% | 311 |
|
|
2014
Q1 | $39K | Hold |
1,000
| – | – | ﹤0.01% | 1713 |
|
|
2013
Q4 | $27K | Hold |
1,000
| – | – | ﹤0.01% | 1771 |
|
|
2013
Q3 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 1784 |
|
|
2013
Q2 | $17K | Buy |
+1,000
| New | +$17K | ﹤0.01% | 1761 |
|